Westwood Holdings Group Inc Moderna, Inc. Transaction History

Westwood Holdings Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $256,643 - $337,035	2,662 Added 41.56%	9,067 $937,000
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $203,820 - $276,111	1,720 Added 36.71%	6,405 $778,000
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $635,567 - $923,038	4,685 New	4,685 $720,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $38,608 - $63,496	-327 Reduced 5.53%	5,588 $660,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $170,307 - $256,761	1,454 Added 32.59%	5,915 $844,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $168,697 - $313,556	-1,334 Reduced 23.02%	4,461 $769,000
Q4 2021 Feb 25, 2022	BUY	$225.82 - $368.51 $1.31 Million - $2.14 Million	5,795 New	5,795 $1.47 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

Stay updated on Westwood Holdings Group Inc with notifications on news.